特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959881

RNAi治療薬の世界市場:COVID-19の影響と分子タイプ別、用途別、投与経路別、エンドユーザー別、地域別の分析

RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Molecule Type (Small Interfering RNAs and MicroRNA ); Application ; Route of Administration ; End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 183 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
RNAi治療薬の世界市場:COVID-19の影響と分子タイプ別、用途別、投与経路別、エンドユーザー別、地域別の分析
出版日: 2020年08月28日
発行: The Insight Partners
ページ情報: 英文 183 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のRNAi治療薬の市場規模は、2019年の6億1,879万米ドルから2027年には12億929万米ドルに拡大すると予測されており、2020年から2027年までのCAGRは8.8%になる見通しです。

当レポートは、世界のRNAi治療薬市場を調査したもので、市場の概況や力学、分子タイプ別、用途別、投与経路別、エンドユーザー別、地域別の分析、新型コロナウイルス感染症(COVID-19)パンデミックの影響、業界の情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 主な調査結果

第3章 調査手法

第4章 市場の情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 市場の主な力学

  • 市場成長促進要因
  • 市場成長阻害要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 世界市場の分析

  • 収益予測と分析
  • 地域別の予測と分析
  • 主要企業の市場でのポジショニング

第7章 市場分析:分子タイプ別

  • 概要
  • 低分子干渉RNA(siRNA)
  • マイクロRNA(miRNA)

第8章 市場分析:用途別

  • 概要
  • 遺伝性疾患
  • 腫瘍
  • 神経変性疾患
  • 心血管疾患
  • 呼吸器疾患
  • 感染症
  • 腎疾患
  • その他

第9章 市場分析:投与経路別

  • 概要
  • 皮内注射
  • 肺送達
  • 静脈注射
  • 腹腔内注射
  • その他

第10章 市場分析:エンドユーザー別

  • 概要
  • 診断検査室
  • 学術研究機関
  • 病院

第11章 各地域の分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第12章 COVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋
  • その他

第13章 業界の情勢

  • 概要
  • 成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • Alnylam Pharmaceuticals, Inc.
  • Benitec Biopharma
  • Sanofi
  • GlaxoSmithKline plc.
  • Olix Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc
  • Quark
  • Rexahn Pharmaceuticals, Inc
  • Silence Therapeutics
  • Arbutus Biopharma

第15章 付録

図表

List Of Tables

  • Table 1. North America RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Germany RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Germany RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Germany RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Germany RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 25. United Kingdom RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 26. United Kingdom RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 27. UK: RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million).
  • Table 28. UK: RNAi Therapeutics Market, End User - Revenue and Forecast to 2027 (USD Million)
  • Table 29. France RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. France RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 31. France RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 32. France RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Spain RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Spain RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Spain RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Spain RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Italy RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Italy RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Italy RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Italy RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Asia Pacific RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
  • Table 42. Asia Pacific RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Asia Pacific RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Asia Pacific RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 45. China RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 46. China RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 47. China RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 48. China RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Japan RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Japan RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Japan RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Japan RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 53. India RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 54. India RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 55. India RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 56. India RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 57. South Korea RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 58. South Korea RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Korea RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Korea RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
  • Table 62. Australia RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Australia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Australia RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Australia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Middle East & Africa RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Middle East & Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Middle East & Africa RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Middle East & Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Saudi Arabia RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Saudi Arabia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Saudi Arabia RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 73. Saudi Arabia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 74. UAE RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 75. UAE RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 76. UAE RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 77. UAE RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 78. South Africa RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 79. South Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 80. South Africa RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 81. South Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 82. South and Central America RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
  • Table 83. South and Central America RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 84. South and Central America RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 85. South and Central America RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 86. Brazil RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 87. Brazil RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 88. Brazil RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 89. Brazil RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Argentina RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
  • Table 91. Argentina RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 92. Argentina RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 93. Argentina RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 94. Recent Inorganic Growth Strategies in the RNAi therapeutics market
  • Table 95. Recent Organic Growth Strategies in the RNAi therapeutics market
  • Table 96. Glossary of Terms, RNAi Therapeutics Market

List Of Figures

  • Figure 1. RNAi Therapeutics Market Segmentation
  • Figure 2. RNAi Therapeutics Market Segmentation, By Region
  • Figure 3. RNAi Therapeutics Market Overview
  • Figure 4. Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market
  • Figure 5. APAC to Show Significant Growth During Forecast Period
  • Figure 6. RNAi Therapeutics Market, by Geography (US$ Million)
  • Figure 7. Global RNAi Therapeutics Market - Leading Country Markets (US$ Million)
  • Figure 8. Global RNAi Therapeutics Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. RNAi Therapeutics Market Impact Analysis of Driver and Restraints
  • Figure 15. Global RNAi Therapeutics Market - Revenue Forecast and Analysis - 2019- 2027
  • Figure 16. Global RNAi Therapeutics Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning of Key Players in Global RNAi Therapeutics Market
  • Figure 18. RNAi Therapeutics Market Share, Molecule Type, 2019 and 2027 (%)
  • Figure 19. Small Interfering RNAs (siRNA): RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 20. MicroRNA (miRNA) Market: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 21. RNAi Therapeutics Market Share, Application, 2019 and 2027 (%)
  • Figure 22. Genetic Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 23. Oncology: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 24. Neurodegenerative Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 25. Cardiovascular Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 26. Respiratory Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 27. Infectious Disease: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 28. Renal Diseases: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 29. Other Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 30. RNAi Therapeutics Market Share, Route of Administration, 2019 and 2027 (%)
  • Figure 31. Intradermal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 32. Pulmonary Delivery: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 33. Intravenous Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 34. Intraperitoneal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 35. Others: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 36. RNAi Therapeutics Market Share, End User, 2019 and 2027 (%)
  • Figure 37. Diagnostic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 38. Research and Academic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 39. Hospitals: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • Figure 40. North America: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 41. North America RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 42. North America: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
  • Figure 43. US: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Canada: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Mexico: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Europe: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 47. Europe RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
  • Figure 49. Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Asia Pacific: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 55. Asia Pacific RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 56. China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Middle East & Africa: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 62. Middle East & Africa RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
  • Figure 64. Saudi Arabia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. UAE: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. South Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. South and Central America: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 68. South and Central America RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 69. South and Central America: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
  • Figure 70. Brazil: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 71. Argentina: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 72. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 73. Impact of COVID-19 Pandemic in Europe Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 75. Impact of COVID-19 Pandemic in Rest of World Country Markets
  • Figure 76. Growth Strategies in the RNAi Therapeutics Market, 2015-2020
目次
Product Code: TIPRE00007157

Title:
RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)); Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, Respiratory Disorders, Infectious Diseases, Renal Diseases, and Other); Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, and Others); End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals), and Geography.

The RNAi therapeutics market was valued at US$ 618.79 million in 2019 and is projected to reach US$ 1,209.29 million by 2027; it is expected to grow at a CAGR of 8.8% during 2020-2027.

Increasing number of investments in RNAi therapy development coupled with growing prevalence of infectious diseases and chronic conditions is anticipated to drive the market growth during the forecast period. However, high cost of RNAi therapies is likely to restraint the growth of the market during the forecast years.

According to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the US have suffered from at least one chronic disease and 4 in 10 people had two or more chronic diseases in 2019. This factor has propelled the growth of healthcare systems across the world. Extensive R&D activities are being conducted by government institutions and academic research centers to discover new drug delivery technologies and deal with the increasing number of patients suffering from infectious diseases (e.g., pneumonia, meningitis, food poisoning, and flu) and chronic conditions (e.g., cancer, diabetes, and cardiovascular conditions).

A study published in 2019 by the American Society for Microbiology revealed that 1.5-4.5 million infections were caused due to Carbapenem-resistant Enterobacteriaceae every year across the world. Additionally, the same risk factor leads to the hospitalization of ~49,000 people each year in the US. According to a study published by UNICEF, in 2018, pneumonia caused the death of nearly 1,755,000 children aged five and below; also, nearly 1,200,000 children across the world lost their lives due to diarrhea. These numbers show that the cases of infectious diseases, especially caused due to bacteria, are increasing day by day across the world. Further, cancer and diabetes are the major cause of death among population across the world. According to a study conducted by the American Cancer Society (ACS), in 2018, about 1,735,350 new cancer cases were diagnosed in the US.

Also, according to the International Diabetes Federation (IDF), in 2017, 46 million Americans were diabetic, and this number is expected to reach 62 million by 2045. The report by IDF has also mentioned that ~425 million people were diagnosed for diabetes in 2017, and this number is expected to reach 629 million by 2045 across the world. Moreover, according to the World Health Organization (WHO), in 2018, about 9.6 million deaths across the world were reported due to cancer. RNAi therapies have significant potential to provide promising treatment for such extensively increasing diseases. Thus, the staggering number of cases necessitates the need for superior treatments, which, in turn, bolsters the growth of the RNAi therapeutics market.

The global impacts of COVID-19 are being felt across several markets. In case of pharmaceutical industry, supply chain operations are significantly hampered due to the pandemic. However, market players in the RNAi therapeutics are focusing on the development of vaccine with the help of gene silencing technology, which might have a positive impact on the market growth during the forecast period.

Based on molecule type, the RNAi therapeutics market is segmented into small interfering RNAs (siRNA) and microRNA (miRNA). The small interfering RNAs (siRNA) segment held alarger share of the market in 2019. However, microRNA (miRNA) segment is estimated to register higher CAGR during the forecast period.

Based on application, the RNAi therapeutics market is segmented into oncology, cardiovascular, respiratory disorders, renal diseases, genetic disorders, neurodegenerative disorders, infectious diseases, and others. In 2019, the oncology segment accounted for the largest share of the global RNAi therapeutics market; whereas, the cardiovascular segment is estimated to register the highest CAGR in the market during the forecast period.

Based on route of administration, the RNAi therapeutics market is segmented into pulmonary delivery, intravenous injections, intradermal injections, intraperitoneal injections, and others. In 2019, the pulmonary delivery segment accounted for the largest share of the global RNAi therapeutics market. However, intravenous injections segment is estimated to register the highest CAGR in the market during the forecast period.

Based on end user, the RNAi therapeutics market is further segmented into research and academic laboratories, hospitals, and diagnostic laboratories. The research and academic laboratories segment held the largest share of the market in 2019 and is expected to register the highest CAGR during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), NHS (National Health Service), and Centers for Disease Control and Preventionare among the major primary and secondary sources referred for preparing this report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the RNAi therapeutics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global RNAI therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global RNAi Therapeutics Market - By Molecule Type
    • 1.3.2 Global RNAi Therapeutics Market - By Application
    • 1.3.3 Global RNAi Therapeutics Market - By Route of Administration
    • 1.3.4 Global RNAi Therapeutics Market - By End User
    • 1.3.5 Global RNAi Therapeutics market - By Geography

2. RNAi Therapeutics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global RNAi Therapeutics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. RNAi Therapeutics Market- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Investments in RNAi Therapies
    • 5.1.2 Rising Prevalence of Chronic Conditions and Infectious Diseases
  • 5.2 Market Restraints
    • 5.2.1 High Cost for RNAi Therapy Development
  • 5.3 Market Opportunities
    • 5.3.1 Significant Number of Pipeline Candidates for Strategic Alliances
  • 5.4 Future Trends
    • 5.4.1 Rising Emphasis on RNA Technologies
  • 5.5 Impact analysis

6. RNAi Therapeutics Market - Global Analysis

  • 6.1 Global RNAi Therapeutics Market Revenue Forecast and Analysis
  • 6.2 Global RNAi Therapeutics Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. RNAi Therapeutics Market- Molecule Type

  • 7.1 Overview
  • 7.2 RNAi Therapeutics Market Share, Molecule Type, 2019 and 2027 (%)
  • 7.3 Small Interfering RNAs (siRNA)
    • 7.3.1 Overview
      • 7.3.1.1 Small Interfering RNAs (siRNA): RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 7.4 MicroRNA (miRNA)
    • 7.4.1 Overview
      • 7.4.1.1 MicroRNA (miRNA) Market: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

8. RNAi Therapeutics Market- Application

  • 8.1 Overview
  • 8.2 RNAi Therapeutics Market Share, Application, 2019 and 2027 (%)
  • 8.3 Genetic Disorders
    • 8.3.1 Overview
      • 8.3.1.1 Genetic Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.4 Oncology
    • 8.4.1 Overview
      • 8.4.1.1 Oncology: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.5 Neurodegenerative Disorders
    • 8.5.1 Overview
      • 8.5.1.1 Neurodegenerative Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.6 Cardiovascular Disorders
    • 8.6.1 Overview
      • 8.6.1.1 Cardiovascular Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.7 Respiratory Disorders
    • 8.7.1 Overview
      • 8.7.1.1 Respiratory Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.8 Infectious Diseases
    • 8.8.1 Overview
      • 8.8.1.1 Infectious Disease: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.9 Renal Diseases
    • 8.9.1 Overview
      • 8.9.1.1 Renal Diseases: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 8.10 Other Disorders
    • 8.10.1 Overview
      • 8.10.1.1 Other Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

9. RNAi Therapeutics Market Market- Route of Administration

  • 9.1 Overview
  • 9.2 RNAi Therapeutics Market Share, Route of Administration, 2019 and 2027 (%)
  • 9.3 Intradermal Injections
    • 9.3.1 Overview
      • 9.3.1.1 Intradermal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 9.4 Pulmonary Delivery
    • 9.4.1 Overview
      • 9.4.1.1 Pulmonary Delivery: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 9.5 Intravenous Injections
    • 9.5.1 Overview
      • 9.5.1.1 Intravenous Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 9.6 Intraperitoneal Injections
    • 9.6.1 Overview
      • 9.6.1.1 Intraperitoneal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 9.7 Other Route of Administrations
    • 9.7.1 Overview
      • 9.7.1.1 Others: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

10. RNAi Therapeutics Market Market- End User

  • 10.1 Overview
  • 10.2 RNAi Therapeutics Market Share, End User, 2019 and 2027 (%)
  • 10.3 Diagnostic Laboratories
    • 10.3.1 Overview
      • 10.3.1.1 Diagnostic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 10.4 Research and Academic Laboratories
    • 10.4.1 Overview
      • 10.4.1.1 Research and Academic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
  • 10.5 Hospitals
    • 10.5.1 Overview
      • 10.5.1.1 Hospitals: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

11. RNAi Therapeutics Market - Geographic Analysis

  • 11.1 North America: RNAi Therapeutics Market
    • 11.1.1 Overview
    • 11.1.2 North America: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
    • 11.1.3 North America: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
    • 11.1.4 North America: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
    • 11.1.5 North America: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
    • 11.1.6 North America: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.1.7 North America: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
    • 11.1.8 US: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.1 US: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.2 US: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.1.8.3 US: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.1.8.4 US: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.1.8.5 US: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.1.9 Canada: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.1 Canada: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.2 Canada: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.1.9.3 Canada RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.1.9.4 Canada: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.1.9.5 Canada: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.1.10 Mexico: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.1 Mexico: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.2 Mexico: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.1.10.3 Mexico: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.1.10.4 Mexico: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.1.10.5 Mexico: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
  • 11.2 Europe: RNAi Therapeutics Market
    • 11.2.1 Overview
    • 11.2.2 Europe: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
    • 11.2.3 Europe RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
    • 11.2.4 Europe RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 11.2.5 Europe RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 11.2.6 Europe RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.2.7 Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
    • 11.2.8 Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.1 Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.2 Germany RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.3 Germany RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.4 Germany RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.5 Germany RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.2.9 UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.1 UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.2 UK RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.3 UK RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.4 UK RNAi Therapeutics Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.5 UK: RNAi Therapeutics Market, End User - Revenue and Forecast to 2027 (USD Million)
    • 11.2.10 France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.1 France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.2 France RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.3 France RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.4 France RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.5 France RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.2.11 Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.1 Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.2 Spain RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.3 Spain RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.4 Spain RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.5 Spain RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.2.12 Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.1 Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.2 Italy RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.3 Italy RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.4 Italy RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.5 Italy RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 11.3 Asia Pacific: RNAi Therapeutics Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
    • 11.3.3 Asia Pacific: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
    • 11.3.4 Asia Pacific: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
    • 11.3.5 Asia Pacific: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
    • 11.3.6 Asia Pacific: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.3.7 Asia Pacific: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
    • 11.3.8 China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.1 China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.2 China: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.3.8.3 China: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.3.8.4 China RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.3.8.5 China RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.3.9 Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.1 Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.2 Japan: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.3.9.3 Japan: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.3.9.4 Japan RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.3.9.5 Japan RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.3.10 India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.1 India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.2 India: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.3.10.3 India: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.3.10.4 India RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.3.10.5 India RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.3.11 South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.1 South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.2 South Korea: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.3.11.3 South Korea: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.3.11.4 South Korea RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.3.11.5 South Korea RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.3.12 Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.1 Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.12.2 Australia: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.3.12.3 Australia: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.3.12.4 Australia RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.3.12.5 Australia RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
  • 11.4 Middle East & Africa: RNAi Therapeutics Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
    • 11.4.3 Middle East & Africa: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
    • 11.4.4 Middle East & Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 11.4.5 Middle East & Africa: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
    • 11.4.6 Middle East & Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.4.7 Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
    • 11.4.8 Saudi Arabia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.1 Saudi Arabia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.2 Saudi Arabia: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.4.8.3 Saudi Arabia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.4 Saudi Arabia: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.4.8.5 Saudi Arabia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.4.9 UAE: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.1 UAE: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.2 UAE: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.4.9.3 UAE RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.4 UAE: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.4.9.5 UAE RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 11.4.10 South Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.1 South Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.2 South Africa: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.4.10.3 South Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.4 South Africa RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.4.10.5 South Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 11.5 South and Central America: RNAi Therapeutics Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
    • 11.5.3 South and Central America: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
    • 11.5.4 South and Central America: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
    • 11.5.5 South and Central America: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
    • 11.5.6 South and Central America: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.5.7 South and Central America: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
    • 11.5.8 Brazil: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.1 Brazil: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.2 Brazil: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.5.8.3 Brazil: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.5.8.4 Brazil: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.5.8.5 Brazil: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
    • 11.5.9 Argentina: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.1 Argentina: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.2 Argentina: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
      • 11.5.9.3 Argentina: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
      • 11.5.9.4 Argentina: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
      • 11.5.9.5 Argentina: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)

12. Impact of COVID-19 Pandemic on Global RNAi Therapeutics Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of World: Impact Assessment of COVID-19 Pandemic

13. RNAi Therapeutics Market -Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the RNAi Therapeutics Market, 2015-2020
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Alnylam Pharmaceuticals, Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Benitec Biopharma
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Sanofi
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 GlaxoSmithKline plc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Olix Pharmaceuticals, Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Arrowhead Pharmaceuticals, Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Quark
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Rexahn Pharmaceuticals, Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Silence Therapeutics
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Arbutus Biopharma
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.